STVN
ANALYST COVERAGE8 analysts
BUY
+38.5%upside to target
L $17.50
Med $24.00consensus
H $32.00
Buy
563%
Hold
338%
5 Buy (63%)3 Hold (38%)0 Sell (-1%)
Full report →
PRICE
Prev Close
17.79
Open
17.23
Day Range17.23 – 17.81
17.23
17.81
52W Range12.89 – 28.00
12.89
28.00
29% of range
VOLUME & SIZE
Avg Volume
580.8K
FUNDAMENTALS
P/E Ratio
28.9x
EPS (TTM)
Div Yield
0.00%
Beta
1.00
Market-like
TECHNICAL
RSI (14)
52
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 20
DEx-Dividend
In 90 days
Aug 17
PDividend Pay
In 97 days
Aug 24
Key MetricsTTM
Market Cap$4.08B
Revenue TTM$1.20B
Net Income TTM$140.95M
Free Cash Flow-$7.11M
Gross Margin29.0%
Operating Margin16.6%
Net Margin11.7%
Return on Equity9.6%
Return on Assets5.5%
Debt / Equity0.29
Current Ratio1.63
EPS TTM$0.52

STVN News

About

founded in 1949, stevanato group is committed to create systems, processes and services that guarantee the integrity of parenteral medicines. it is comprised of two operational divisions: - pharmaceutical systems (ompi and balda brands): specialized in ready-to-use glass containers and bulk primary packaging (syringes, cartridges, vials and ampoules); high quality and high precision plastic solutions for diagnostic, pharmaceutical and medical device applications. - engineering systems (spami, optrel, innoscan and svm brands): specialized in glass forming technology, inspection systems, assembly, packaging machines and serialization solutions for the pharmaceutical industry. these two divisions enjoy a close, synchronous relationship, featuring daily exchanges which ensure that stevanato group has complete control over the entire production process, from purchasing the finest raw materials to offering exceptional after-sales customer service. the group also benefits from the sglab activ

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Franco Moro
Country
Italy
Franco StevanatoChief Executive Officer & Executive Chairman
Marco Dal LagoChief Financial Officer
Mauro StocchiChief Business Officer
Raffaele PacePresident of Engineering Business Unit
Carla CostaChief Human Resources Officer
Lisa MilesChief Communications & Investor Relations Officer
Michele MonicoPresident of DDS & IVD Business Unit